Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
No one on the platform currently holds PNT.
No tracked institution reports a position in PNT as of their last filing.
No one on the platform has traded PNT yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Beat consensus in 7 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2023-11-13 | $-0.30 | $-0.23 | +23.3% |
| 2023-08-14 | $-0.29 | $-0.24 | +17.2% |
| 2023-05-15 | $-0.32 | $-0.16 | +50.0% |
| 2023-03-27 | $-0.26 | $1.53 | +688.5% |
| 2022-11-14 | $-0.28 | $-0.26 | +7.1% |
| 2022-08-12 | $-0.22 | $-0.27 | -22.7% |
| 2022-05-13 | $-0.20 | $-0.18 | +10.0% |
| 2022-03-25 | $-0.20 | $-0.16 | +20.0% |
| $1.1B |
| — |
| ETHZEthzilla Corp. | $3.53 | +0.00% | $56M | — |
| GRCLGracell Biotechnologies Inc. | $10.25 | +0.05% | $198M | — |
Source: Financial Modeling Prep · peers by sector/industry
We all know what direction $RADX going following the path of $RYZB and $PNT Radiopharma Theranostics CEO came from Novartis which produced the 2 blockbuster Pluvicto and Lutathera. And Lantheus just upped their ownership by buying stock at $11.34 (They are the market leader)
View on StockTwits ↗$YMAB Lantheus the $7 billion radioisotope imaging giant just bought $5 million of the $36 million market cap Radiopharma Theranostics at over double current stock price. They own 12% and are throwing them money to work on their trials in Australia. + flush pipeline of Lu-177 therapeutics and imaging agents in the clinic. $CLRB $PNT $RADX
View on StockTwits ↗
https://nfne.ws/216454 $PNT #Banking #FinancialServices #NASDAQ #Investing
View on StockTwits ↗
@FonsieTrader - objectively speaking, this is a grossly undervalued company as compared to it's peers....and the space is HOT! -- $FUSN, $PNT, $CATX, mariana With a late stage asset (Iomab-B) that had knockout Ph3 results it appears to be more of a valuation stand-off between BP and ATNM. I think a well negotiated CVR gets this over the finish line in '24. I'll invite @resume777 , @Karmic to add their take on this as well
View on StockTwits ↗
$ATNM I presume many like me who owned both $ATNM and $FUSN and who made a killing on $FUSN are now doubling down into $ATNM. Also a bunch of people who knew little to nothing of RadioPharma are now fully awake after $PNT, $RYZB and now $FUSN were bought out for impressive premiums. At 200 million of market cap acquiring a sizeable position will need a lot of small shareholders to sell to the big fish. This company is extraordinarily cheap by any metric.
View on StockTwits ↗
$PNT $RYZB $CNSY $FUSN $NBTX another one bites the dust. Bye Fusion👋
View on StockTwits ↗
@resume777 what happened to the $LLY and $PNT acquisition? cant read pickerbefores posts
View on StockTwits ↗
@Pickerbefore that's what happened with the $LLY and $PNT acquisition.
View on StockTwits ↗
$CATX seems that PB is best radioisotope - this was also confirmed when $PNT (just $LLY before BO was announced signed a strategic supply deal for PB… so $catx is leading with this tech… while most others are using Actinium
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.